These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

469 related articles for article (PubMed ID: 26763008)

  • 1. The Edmonton Symptom Assessment System: Poor performance as screener for major depression in patients with incurable cancer.
    Brenne E; Loge JH; Lie H; Hjermstad MJ; Fayers PM; Kaasa S;
    Palliat Med; 2016 Jun; 30(6):587-98. PubMed ID: 26763008
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Establishing Cutoff Points for Defining Symptom Severity Using the Edmonton Symptom Assessment System-Revised Japanese Version.
    Yamaguchi T; Morita T; Nitto A; Takahashi N; Miyamoto S; Nishie H; Matsuoka J; Sakurai H; Ishihara T; Tarumi Y; Ogawa A
    J Pain Symptom Manage; 2016 Feb; 51(2):292-7. PubMed ID: 26598039
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Edmonton symptom assessment scale: Italian validation in two palliative care settings.
    Moro C; Brunelli C; Miccinesi G; Fallai M; Morino P; Piazza M; Labianca R; Ripamonti C
    Support Care Cancer; 2006 Jan; 14(1):30-7. PubMed ID: 15937688
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The utility of the Edmonton Symptom Assessment System in screening for anxiety and depression.
    Bagha SM; Macedo A; Jacks LM; Lo C; Zimmermann C; Rodin G; Li M
    Eur J Cancer Care (Engl); 2013 Jan; 22(1):60-9. PubMed ID: 22694595
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Depression-A Major Contributor to Poor Quality of Life in Patients With Advanced Cancer.
    Grotmol KS; Lie HC; Hjermstad MJ; Aass N; Currow D; Kaasa S; Moum TÅ; Pigni A; Loge JH;
    J Pain Symptom Manage; 2017 Dec; 54(6):889-897. PubMed ID: 28803091
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Diagnostic evaluation of the hospital depression scale (HADS) and the Beck depression inventory II (BDI-II) in adults with congenital heart disease using a structured clinical interview: Impact of depression severity.
    Westhoff-Bleck M; Winter L; Aguirre Davila L; Herrmann-Lingen C; Treptau J; Bauersachs J; Bleich S; Kahl KG
    Eur J Prev Cardiol; 2020 Mar; 27(4):381-390. PubMed ID: 31349778
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Symptom Checklist-core depression (SCL-CD6) scale: psychometric properties of a brief six item scale for the assessment of depression.
    Magnusson Hanson LL; Westerlund H; Leineweber C; Rugulies R; Osika W; Theorell T; Bech P
    Scand J Public Health; 2014 Feb; 42(1):82-8. PubMed ID: 23982463
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Predicting future major depression and persistent depressive symptoms: Development of a prognostic screener and PHQ-4 cutoffs in breast cancer patients.
    Weihs KL; Wiley JF; Crespi CM; Krull JL; Stanton AL
    Psychooncology; 2018 Feb; 27(2):420-426. PubMed ID: 28600855
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Hospital Anxiety and Depression Scale (HADS) and the 9-item Patient Health Questionnaire (PHQ-9) as screening instruments for depression in patients with cancer.
    Hartung TJ; Friedrich M; Johansen C; Wittchen HU; Faller H; Koch U; Brähler E; Härter M; Keller M; Schulz H; Wegscheider K; Weis J; Mehnert A
    Cancer; 2017 Nov; 123(21):4236-4243. PubMed ID: 28654189
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of two instruments of perceived symptom intensity in palliative care patients in an outpatient clinic.
    Saetra P; Fossum M; Svensson E; Cohen MZ
    J Clin Nurs; 2016 Mar; 25(5-6):799-810. PubMed ID: 26813779
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The cut-off points of the Depression and Somatic Symptoms Scale and the Hospital Anxiety and Depression Scale in detecting non-full remission and a current major depressive episode.
    Hung CI; Liu CY; Wang SJ; Yao YC; Yang CH
    Int J Psychiatry Clin Pract; 2012 Mar; 16(1):33-40. PubMed ID: 22122659
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Performance of the Hospital Anxiety and Depression Scale as a screening tool for major depressive disorder in cancer patients.
    Walker J; Postma K; McHugh GS; Rush R; Coyle B; Strong V; Sharpe M
    J Psychosom Res; 2007 Jul; 63(1):83-91. PubMed ID: 17586341
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Disagreement and factors between symptom on self-report and clinician rating of major depressive disorder: A report of a national survey in China.
    Lyu D; Wu Z; Wang Y; Huang Q; Wu Z; Cao T; Zhao J; Cao Y; Hu Y; Chen J; Wang Y; Su Y; Zhang C; Peng D; Li Z; Cao L; Hong W; Fang Y
    J Affect Disord; 2019 Jun; 253():141-146. PubMed ID: 31035214
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Edmonton Symptom Assessment System (ESAS) as a screening tool for depression and anxiety in non-advanced patients with solid or haematological malignancies on cure or follow-up.
    Ripamonti CI; Bandieri E; Pessi MA; Maruelli A; Buonaccorso L; Miccinesi G
    Support Care Cancer; 2014 Mar; 22(3):783-93. PubMed ID: 24276952
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Diagnostic accuracy, internal consistency, and convergent validity of the Greek version of the patient health questionnaire 9 in diagnosing depression in rheumatologic disorders.
    Hyphantis T; Kotsis K; Voulgari PV; Tsifetaki N; Creed F; Drosos AA
    Arthritis Care Res (Hoboken); 2011 Sep; 63(9):1313-21. PubMed ID: 21618450
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Validation of the French Version of the Edmonton Symptom Assessment System.
    Pautex S; Vayne-Bossert P; Bernard M; Beauverd M; Cantin B; Mazzocato C; Thollet C; Bollondi-Pauly C; Ducloux D; Herrmann F; Escher M
    J Pain Symptom Manage; 2017 Nov; 54(5):721-726.e1. PubMed ID: 28751077
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Modified Edmonton Symptom Assessment System including constipation and sleep: validation in outpatients with cancer.
    Hannon B; Dyck M; Pope A; Swami N; Banerjee S; Mak E; Bryson J; Rodin G; Ridley J; Lo C; Le LW; Zimmermann C
    J Pain Symptom Manage; 2015 May; 49(5):945-52. PubMed ID: 25523890
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Screening for major depression in private practice.
    Bernstein IH; Wendt B; Nasr SJ; Rush AJ
    J Psychiatr Pract; 2009 Mar; 15(2):87-94. PubMed ID: 19339842
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Development of a French Version of the Edmonton Symptom Assessment System-Revised: A Pilot Study of Palliative Care Patients' Perspectives.
    Nekolaichuk C; Huot A; Gratton V; Bush SH; Tarumi Y; Watanabe SM
    J Palliat Med; 2017 Sep; 20(9):966-976. PubMed ID: 28448236
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Validation of the Hospital Anxiety and Depression Scale for use with multiple sclerosis patients.
    Honarmand K; Feinstein A
    Mult Scler; 2009 Dec; 15(12):1518-24. PubMed ID: 19965520
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.